OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
Santiago Perez‐Lloret, Daniel P. Cardinali
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 39
Santiago Perez‐Lloret, Daniel P. Cardinali
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 39
Showing 26-50 of 39 citing articles:
Mixed ligand complex: Synthesis, characterization, and investigation of biomedical activity
Elaf A. Mousa, Basim I. Al-Abdaly
Baghdad Science Journal (2024), pp. 3122-3122
Open Access | Times Cited: 1
Elaf A. Mousa, Basim I. Al-Abdaly
Baghdad Science Journal (2024), pp. 3122-3122
Open Access | Times Cited: 1
Pharmacological Interventions for REM Sleep Behavior Disorder in Parkinson's Disease: A Systematic Review
Junqiang Yan, Anran Liu, Jiarui Huang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 10
Junqiang Yan, Anran Liu, Jiarui Huang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 10
L-3,4-Dihydroxyphenylalanine Recovers Circadian Rhythm Disturbances in the Rat Models of Parkinson's Disease by Regulating the D1R-ERK1/2-mTOR Pathway
Shuyuan Yang, Ying Wan, Na Wu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 8
Shuyuan Yang, Ying Wan, Na Wu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 8
Melatonin in Aging and Aging-Related Disorders
Síbel Süzen
(2023), pp. 155-189
Closed Access | Times Cited: 3
Síbel Süzen
(2023), pp. 155-189
Closed Access | Times Cited: 3
Melatonin in the regulation of human life and its role in development pathology
A. V. Shilova, N. I. Ananyeva, N. Yu. Safonova, et al.
V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY (2023)
Open Access | Times Cited: 3
A. V. Shilova, N. I. Ananyeva, N. Yu. Safonova, et al.
V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY (2023)
Open Access | Times Cited: 3
Screening and Targeting Risk Factors for Prodromal Synucleinopathy: Taking Steps toward a Prescriptive Multi-modal Framework
Lee E. Neilson, Joseph F. Quinn, Miranda M. Lim
Aging and Disease (2023)
Open Access | Times Cited: 3
Lee E. Neilson, Joseph F. Quinn, Miranda M. Lim
Aging and Disease (2023)
Open Access | Times Cited: 3
Fine-tuning the circadian system with light treatment for Parkinson’s disease: an in-depth, critical review
Gregory L. Willis, Stuart M. Armstrong
Reviews in the Neurosciences (2023)
Closed Access | Times Cited: 3
Gregory L. Willis, Stuart M. Armstrong
Reviews in the Neurosciences (2023)
Closed Access | Times Cited: 3
Neuroprotection induced by phytomelatonin
Charles Obinwanne Okoye, Emmanuel Sunday Okeke, Kingsley Ikechukwu Chukwudozie, et al.
Elsevier eBooks (2024), pp. 1739-1755
Closed Access
Charles Obinwanne Okoye, Emmanuel Sunday Okeke, Kingsley Ikechukwu Chukwudozie, et al.
Elsevier eBooks (2024), pp. 1739-1755
Closed Access
A Flexible Molecularly Imprinted Electrochemical Sensor Based on Cuxo/Mxene for Quantitative Detection of Melatonin in Human Urine
Xinyu Wang, Wenbin Wang, Meng Gao, et al.
(2024)
Closed Access
Xinyu Wang, Wenbin Wang, Meng Gao, et al.
(2024)
Closed Access
Indoleamine 2,3-dioxygenase (IDO1) – Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson’s Disease?
Milene Gonçalves, Paulo Rodrigues‐Santos, Cristina Januário, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112062-112062
Open Access
Milene Gonçalves, Paulo Rodrigues‐Santos, Cristina Januário, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112062-112062
Open Access
In vitro modelling of Parkinson's disease using 6-OHDA is associated with increased NQO2 activity
Ekaterina R. Verbovaya, Ilya A. Kadnikov, И. О. Логвинов, et al.
Toxicology in Vitro (2024) Vol. 101, pp. 105940-105940
Closed Access
Ekaterina R. Verbovaya, Ilya A. Kadnikov, И. О. Логвинов, et al.
Toxicology in Vitro (2024) Vol. 101, pp. 105940-105940
Closed Access
Differentiated Embryo-Chondrocyte Expressed Gene1 and Parkinson’s Disease: New Insights and Therapeutic Perspectives
Chunyan Wang, Zheng-Jie Qiu, Ping Zhang, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 11, pp. 2251-2265
Open Access | Times Cited: 1
Chunyan Wang, Zheng-Jie Qiu, Ping Zhang, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 11, pp. 2251-2265
Open Access | Times Cited: 1
Melatonin and Inflammatory and Immune-Modulated Diseases: New Applications of a Metabolite Also Produced by Plants
Lucas Fornari Laurindo, Bárbara de Oliveira Zanuso, Élen Landgraf Guiguer, et al.
Reference series in phytochemistry (2023), pp. 1-26
Closed Access
Lucas Fornari Laurindo, Bárbara de Oliveira Zanuso, Élen Landgraf Guiguer, et al.
Reference series in phytochemistry (2023), pp. 1-26
Closed Access
Melatonin: A Promising Drug to Ameliorate Main Human Space Exploration Risks
Santiago A. Plano, Víctor Demaría Pesce, Daniel P. Cardinali, et al.
Springer eBooks (2022), pp. 1015-1028
Closed Access
Santiago A. Plano, Víctor Demaría Pesce, Daniel P. Cardinali, et al.
Springer eBooks (2022), pp. 1015-1028
Closed Access
Melatonin: A Promising Drug to Ameliorate Main Human Space Exploration Risks
Santiago A. Plano, Víctor Demaría Pesce, Daniel P. Cardinali, et al.
Springer eBooks (2021), pp. 1-15
Closed Access
Santiago A. Plano, Víctor Demaría Pesce, Daniel P. Cardinali, et al.
Springer eBooks (2021), pp. 1-15
Closed Access
